Florida Valve Symposium

Florida Valve ‘10 is designed to be an innovative educational experience, drawing upon the knowledge of the world’s leaders in Cardiac Surgery, Percutaneous Interventions, Cardiovascular Imaging, Endovascular Surgery and Cardiac Anesthesiology as they present current and new knowledge centering on innovations in the diagnosis and treatment of valvular heart disease and diseases of the aorta.

Valvular heart disease has become a growing focus of many physicians worldwide. The dramaticadvances in cardiac surgery and percutaneous interventions paralleled by the advancing age of our population have led to management of valvular heart disease. Furthermore, the advancing percutaneous therapies worldwide have led cardiovascular providers to have similar extensions in experience to the diagnosis and treatment of the diseases of the aorta and peripheral vascular system. Florida Valve ‘10 will build upon the information of earlier symposia to discuss not only the recent advances in interventional and surgical techniques in valvular heart disease but further delve into how advances in technology also have application and necessary knowledge on handling diseases of the aorta. Remaining unique among the educational field by providing equal representation of the world’s leaders in Cardiac Surgery and Interventional Cardiology, Florida Valve ’10 will also present information on the strategic direction of the field of valvular heart disease that may enhance practice. Also represented will be Clinical Cardiologists, who are experts in imaging and management of valvular heart disease, as well as authors on the latest ACC/AHA Guidelines for Valvular Heart Disease. This year world experts in Endovascular Therapy of the aorta will be present to enhance the translational knowledge between specialties. These experts bring a wealth of clinical knowledge and will provide the latest on diagnosis and surgical and percutaneous interventions. With faculty equally represented by the foremost leaders in Cardiac Surgery, Cardiology and Endovascular Therapy together in a dynamic and personal interchange, the audience will not only learn the current advances in treatment of valvular heart disease but will enjoy lively and direct personal one-on-one discussions with the faculty in an open and friendly environment.

HIGHLIGHTS:

State-of-the-Art information concerning surgical and percutaneous treatments of valvular heart disease, provided by the world’s foremost Cardiologists and Cardiac Surgeons
Frank discussion of how the clinical application of the ACC/AHA 2006 valve guidelines are impacting outcomes in valvular heart disease Update on recent advances in 3D Echo and Cardiac CT/MR Imaging for Valvular Assessment
Current status and selection of cardiac surgical approach to Aortic Valve Disease, Aortic Root Disease, Mitral Valve Disease, Aortic Aneurysms of the Arch and Descending Aorta
State-of-the-Art discussion of Percutaneous – Catheter-based therapies and treatments for Aortic and Mitral Valve Disease
State-of-the-Art review of the medical, percutaneous and surgical management of diseases of the aorta and latest evidence on how to determine optimal therapy with particular concentration on evidence-based careful adoption of new treatment modalities
Discussion on balanced application of new FDA approved techniques for valvular and aortic therapy along with methods to handle and avoid potential complications for the new adopter
Dynamic roundtable discussions, giving adequate time for State-of-the-Art interactions between the foremost Cardiac Surgeons, Interventional Cardiologists, Diagnostic Cardiologists and Endovascular Specialists on the Faculty
Unique Wet Lab providing a hands-on experience to learn not only the important anatomical relationships critical to understanding disease mechanisms and surgical percutaneous approach, but also insights into anatomic correlation to echocardiographic findings and performance of transesophageal echocardiolography, as well as learning surgical procedures including valve repair procedures

OBJECTIVES:
Upon completion of the program, the participants should be able to:

Establish how evidence-based diagnostic information can be applied to the identification of Aortic Valve Disease, Aortic Root Abnormalities, Mitral Valve Disease, and Diseases of the Aorta and how the ACC-AHA guidelines are having an impact in outcomes
Identify the clinical utility of the newest cardiovascular imaging modalities (3-D Echo, Multi-slice cardiac CT, cardiac MRI) for the diagnosis and triaging management of both the surgical and percutaneous approach to aortic valve abnormalities and mitral valve abnormalities
Determine optimal timing for surgical intervention in both asymptomatic patients with severe valvular heart disease, as well as those complex situations where multiple operative procedures may be necessary
Determine the wider applicability and potential impact of emerging percutaneous valve technology on the treatment of aortic stenosis and mitral regurgitation
Determine how to choose between the medical and surgical options available in the treatment of diseases of the thoracic aorta including percutaneous modalities
Evaluate and deliver the optimal surgical approaches to mitral valve, tricuspid valve, and aortic valve disease including primary reparative techniques and new prostheses choices
Apply newer surgical and catheter-based interventional therapies in the management of valvular heart disease patients and diseases of the aorta
Determine the changes in healthcare policy and strategies for the optimal delivery of cardiovascular care
Demonstrate, in an isolated pig heart, valve repair or replacement techniques and acquire a better appreciation of cardiac valvular anatomy
Acquire improved appreciation of three dimensional anatomy with echocardiographic correlation of image simulation and pig heart anatomic dissection

To download and view the complete program, click on the following link.

Program agenda

This file can be viewed using the free Adobe Reader, which can be downloaded here.

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the American Society of Echocardiography and Tampa Bay Heart Foundation. The American Society of Echocardiography is accredited by the ACCME to provide continuing medical education for physicians.

The American Society of Echocardiography designates this educational activity for a maximum of 16 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ARDMS and CCI recognize ASE’s certificates and have agreed to honor the credit hours toward their registry requirements for sonographers.

The American Society of Echocardiography is committed to ensuring that its educational mission and all sponsored educational programs are not influenced by the special interests of any corporation or individual, and its mandate is to retain only those speakers whose financial interests can be effectively resolved to maintain the goals and educational integrity of the program. While a monetary or professional affiliation with a corporation does not necessarily influence a speaker’s presentation, the Essential Areas and policies of the ACCME require that any relationships that could possibly conflict with the educational value of the program be resolved prior to the educational session and disclosed to the audience.